| 1 |
Shi H, Duan J, Chen Z, Huang M, Han W, Kong R, Guan X, Qi Z, Zheng S, Lu M. A prognostic gene signature for gastric cancer and the immune infiltration-associated mechanism underlying the signature gene, PLG. Clin Transl Oncol 2023;25:995-1010. [PMID: 36376702 DOI: 10.1007/s12094-022-03003-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Zeng C, He R, Dai Y, Lu X, Deng L, Zhu Q, Liu Y, Liu Q, Lu W, Wang Y, Jin J. Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1069204] [Reference Citation Analysis]
|
| 3 |
Bao T, Feng L, Cho S, Yu H, Jin W, Dai L, Zhang J, Bai L, Fu M, Chen Y. RNA-Seq Reveals Protective Mechanisms of Mongolian Medicine Molor-Dabos-4 on Acute Indomethacin-Induced Gastric Ulcers in Rats. Genes (Basel) 2022;13. [PMID: 36292625 DOI: 10.3390/genes13101740] [Reference Citation Analysis]
|
| 4 |
Song Y, Zhang Z, Zhang B, Zhang W. CD8+ T cell-associated genes MS4A1 and TNFRSF17 are prognostic markers and inhibit the progression of colon cancer. Front Oncol 2022;12:941208. [DOI: 10.3389/fonc.2022.941208] [Reference Citation Analysis]
|
| 5 |
Zheng X, Wang Y, Chen Y, Pan J. Gastric Cancer Subtypes in Tumour and Nontumour Tissues by Immunologic and Hallmark Gene Sets. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/7887711] [Reference Citation Analysis]
|
| 6 |
Gao Y, Wang K, Tang X, Niu J, Wang J. A Pilot Study of Prognostic Value of Metastatic Lymph Node Count and Size in Patients with Different Stages of Gastric Carcinoma. CMAR 2022;Volume 14:2055-64. [DOI: 10.2147/cmar.s352334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Chen D, Zhang R, Xie A, Yuan J, Zhang J, Huang Y, Zhang H, Zhang F. Clinical correlations and prognostic value of Nudix hydroxylase 10 in patients with gastric cancer. Bioengineered 2021;12:9779-89. [PMID: 34696672 DOI: 10.1080/21655979.2021.1995104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 8 |
Zhao Y, Hu S, Zhang J, Cai Z, Wang S, Liu M, Dai J, Gao Y. Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis. Bioengineered 2021;12:5641-54. [PMID: 34506251 DOI: 10.1080/21655979.2021.1967067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Ren J, Chen S, Ye F, Gong X, Lu Y, Cai Q, Chen Y. Exploration of differentially-expressed exosomal mRNAs, lncRNAs and circRNAs from serum samples of gallbladder cancer and xantho-granulomatous cholecystitis patients. Bioengineered 2021;12:6134-43. [PMID: 34486489 DOI: 10.1080/21655979.2021.1972780] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Guo H, Yang J, Liu S, Qin T, Zhao Q, Hou X, Ren L. Prognostic marker identification based on weighted gene co-expression network analysis and associated in vitro confirmation in gastric cancer. Bioengineered 2021;12:4666-80. [PMID: 34338150 DOI: 10.1080/21655979.2021.1957645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
